Evercyte contributing to reduce animal testing at key events
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
By Giulia Corso|2023-12-07T08:27:20+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
By Giulia Corso|2023-11-22T14:26:44+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our services
By Giulia Corso|2023-10-27T13:05:07+00:00October 27th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, AustriaWe participated to the first MOVE symposium held
By Giulia Corso|2023-12-01T09:15:19+00:00September 19th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
By Giulia Corso|2023-07-11T09:18:04+00:00May 4th, 2023|EU funded project, Extracellular vesicles and ageing, mesenchymal stromal cells|
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on
By admin|2021-04-09T07:40:43+00:00April 9th, 2021|recent highlights EV|
Analysis of miRNA cargo of extracellular vesicles from Wharton´s Jelly derived mesenchymal stem cells WJ-MSC/TERT273 application: characterization and quality control for stable production of extracellular